GlassScriptPhysician profile
Yuchi P Peng
NPI 1023058195
$870.95
in general payments reported to CMS, 2019-2025
22 companies · $74.04 in 2025
The $74.04 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $60.40 · 2021: $177 · 2023: $29.01 · 2024: $31.59 · 2025: $74.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $162.80 | 2019-2021 | |
| Varian Medical Systems, INC. | $103.83 | 2019 | |
| Novocure INC. | $79.53 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.35 | 2019-2020 | |
| Tesaro, INC. | $50.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $34.51 | 2019-2020 | |
| Blue Earth Diagnostics | $31.59 | 2024 | |
| Pfizer INC. | $31.25 | 2019-2020 | |
| Incyte Corporation | $29.01 | 2023 | Monjuvi |
| Dendreon Pharmaceuticals LLC | $28.13 | 2019 | |
| Emd Serono, INC. | $26.05 | 2019 | |
| Merck Sharp & Dohme LLC | $25.59 | 2025 | Keytruda |
| Daiichi Sankyo INC. | $25.05 | 2025 | Datroway |
| Genzyme Corporation | $23.55 | 2021 | |
| Janssen Biotech, INC. | $23.40 | 2025 | Darzalex, Tecvayli, Talvey |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21.22 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $20.97 | 2019 | |
| Mylan Institutional INC. | $19.75 | 2019 | |
| Lilly USA, LLC | $18.55 | 2021 | |
| Astellas Pharma US INC | $16.14 | 2021 | |
| Octapharma USA, INC. | $15.47 | 2019 | |
| Eisai INC. | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuchi Peng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.